Climate Change Data

InnoCare Pharma Limited 諾誠健華醫藥有限公司

Climate Impact & Sustainability Data (2019, 2020, 2022, 2023)

Reporting Period: 2019

Environmental Metrics

Total Carbon Emissions:2,120 tons of CO2 (indirect emissions from office operations and projects under construction)
Total Energy Consumption:1,428,600 kWh of electricity, 7,854.55 GJ of heat
Water Consumption:13,200 tons
Waste Generated:Hazardous waste: 20.20 tons; General solid waste: 36.10 tons

ESG Focus Areas

  • Corporate governance
  • Anti-corruption
  • Talent attraction and retention
  • R&D and innovation
  • Product quality and safety
  • Waste management
  • Chemical management
  • Animal welfare
  • Career development
  • Occupational health and safety (OHS)
  • Supply chain management
  • Intellectual property protection
  • Data and privacy protection
  • Energy consumption
  • Emissions management
  • Legal employment
  • Community contribution
  • Climate change

Environmental Achievements

  • Invested RMB727,700 in environmental protection and encountered no environmental accidents such as chemical leakage.
  • Saved about 61,000 kWh of electricity through energy-saving measures.
  • Consumed 13,200 tons of water during the reporting period with no issues in sourcing fit-for-purpose water.
  • Registered no soil erosion incidents in the project construction area and no adverse impact on the environment during the reporting period.

Social Achievements

  • No work-related accidents; zero hours lost due to work-related injuries.
  • 100% safety training coverage with 30 hours of per-capita training.
  • Total person times of staff training reached 4,676.
  • Donated RMB one million to the Chinese Red Cross Foundation to help control the COVID-19 pandemic.
  • Donated surgical masks to Shanghai Oriental Hospital and an American organization.

Governance Achievements

  • Established a Safety Committee to implement a safety responsibility system and regulate EHS management.
  • Established rigorous Quality Risk Management Procedures.
  • Developed a series of 168 clinical standard operating procedures (SOPs).
  • No cases of corruption during the reporting period.

Climate Goals & Targets

Environmental Challenges

  • Supply chain risks in areas including compliance of suppliers, intellectual property infringement, raw material and component quality, severe weather and natural or man-made disaster.
Mitigation Strategies
  • Clear systems and specifications, management measures, and supplier training to reduce supply chain risks.
  • On-site supplier audits for raw and auxiliary materials and internal packaging materials.
  • EHS audit and supervision requirements for contractor selection on projects under construction.

Supply Chain Management

Supplier Audits: Annual audits conducted on suppliers of raw and auxiliary materials and internal packaging materials.

Responsible Procurement
  • Purchase Management System
  • Warehouse Management System
  • Plan Management System
  • Supplier Management
  • Material Supplier Management
  • Consumables Supplier Management
  • Supplier Monitoring and Maintenance
  • Supplier Complaint Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards for Sustainability Reporting, ESG Reporting Guide

Reporting Period: 2020

Environmental Metrics

Total Carbon Emissions:2,599.03 tonnes CO2e
Scope 1 Emissions:281.29 tonnes CO2e
Scope 2 Emissions:2,317.74 tonnes CO2e
Total Energy Consumption:2,895,162 kWh
Water Consumption:56,311 tonnes
Waste Generated:1,955.66 tonnes (hazardous: 30.10 tonnes; non-hazardous: 1,925.56 tonnes)
Carbon Intensity:50.04 tonnes CO2e per square meter, 57.49 tonnes CO2e per employee

ESG Focus Areas

  • Environmental Protection
  • People-oriented
  • Responsible Operation
  • Product Liability
  • Community Engagement

Environmental Achievements

  • Reduced experimental wastewater discharge by 49% compared to 2019 (1,208 tonnes vs 2,370 tonnes)
  • Implemented energy-saving measures such as LED lighting and temperature controls in offices and laboratories.
  • Implemented waste reduction initiatives, including paperless office initiatives and waste recycling programs.

Social Achievements

  • No labor disputes or child labor incidents.
  • No work-related deaths or lost workdays due to injuries.
  • Provided various employee benefits, including social insurance, housing provident fund, and other welfare payments.
  • Conducted extensive employee training programs (2,081 female and 2,535 male employee training hours).

Governance Achievements

  • Established an ESG working group to oversee ESG policies and strategies.
  • Implemented an internal audit management system to strengthen internal controls and prevent illegal activities.
  • Formulated anti-commercial bribery and conflict of interest management agreements.
  • Established whistleblowing procedures for reporting unethical behavior.

Climate Goals & Targets

Environmental Challenges

  • Large-scale construction of Guangzhou manufacturing facility impacting energy and water consumption.
  • Managing environmental risks during the construction phase of the Guangzhou facility.
Mitigation Strategies
  • Regular monitoring and evaluation of environmental risks during construction.
  • Implementation of drainage ditches, sediment deposit ponds, and other greening measures to mitigate environmental impact.

Supply Chain Management

Supplier Audits: 844 suppliers (783 in Mainland China, 61 overseas)

Responsible Procurement
  • Purchasing Management System
  • Supplier Management
  • Material Supplier Management
  • Consumables Supplier Management
  • Contractor Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Hong Kong Stock Exchange ESG Reporting Guide

Awards & Recognition

  • 2020 Humanitarian Dedication Angel

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:9,835.80 tons of CO2 equivalent
Scope 1 Emissions:0 tons of CO2 equivalent
Scope 2 Emissions:9,835.80 tons of CO2 equivalent
Total Energy Consumption:9,380.31 MWh
Water Consumption:124,940.00 m3
Waste Generated:1,189.15 tons (hazardous and non-hazardous)

ESG Focus Areas

  • Corporate Governance
  • Product and Service Responsibility
  • Talent Development
  • Environmental Protection
  • Responsible Operation
  • Social Welfare

Environmental Achievements

  • Obtained ISO 14001 Environmental Management System Certification at Guangzhou production base.
  • Completed construction of biologics R&D platform project with environmental impact assessments and mitigation measures.

Social Achievements

  • Upgraded supplementary commercial insurance for employees, including coverage for two children and critical illness insurance.
  • Provided various employee care initiatives, including assistance for employees in economic difficulty, health supplies distribution, and psychological counseling.
  • Achieved 100% employee training coverage.

Governance Achievements

  • Issued anti-corruption and anti-bribery policies.
  • Formulated the Reporting Policy for managing reporting incidents and protecting reporters.
  • No major or significant deficiencies identified in internal control.

Climate Goals & Targets

Environmental Challenges

  • Meeting more stringent domestic and international climate policies, laws, and regulations.
  • Potential damage to reputation due to insufficient climate response actions.
  • Potential impact of acute and chronic physical climate risks on operations and finances.
Mitigation Strategies
  • Analyzing potential financial impact of climate risks and opportunities.
  • Developing future plans integrating climate change risk management into overall operational risk management.
  • Implementing measures to improve resource efficiency and develop resilience to climate change.

Supply Chain Management

Supplier Audits: 0 suppliers evaluated for environmental and social impacts

Responsible Procurement
  • Multi-dimensional background investigation on suppliers.
  • Regular meetings and communication with key suppliers.
  • Periodic quality history evaluations.

Climate-Related Risks & Opportunities

Physical Risks
  • Acute physical risks (extreme weather events)
  • Chronic physical risks (long-term weather pattern changes)
Transition Risks
  • Policies, laws, and regulations
  • Reputation
Opportunities
  • Resource efficiency
  • Resilience

Reporting Standards

Frameworks Used: HKEX ESG Reporting Guide, Shanghai Stock Exchange Guidelines No. 1 and No. 2

Certifications: ISO 14001, ISO 45001

Awards & Recognition

  • Golden Yue Award - 2022 Company of the Year Public Responsibility
  • Most Valuable Pharmaceutical and Medical Company
  • Most Valuable IPO of the Year
  • Best IR Award

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:12,134.54 tCO2e/year
Scope 1 Emissions:19.95 tCO2e/year
Scope 2 Emissions:12,114.59 tCO2e/year
Total Energy Consumption:24,091.28 MWh/year
Water Consumption:134,988 m3/year
Waste Generated:1,418.73 tons/year (hazardous and non-hazardous combined)
Carbon Intensity:0.16 tons of CO2 equivalent/RMB0’000 in 2023

ESG Focus Areas

  • Corporate Governance
  • Product and Service Responsibility
  • Talent Development
  • Environmental Protection
  • Social Welfare

Environmental Achievements

  • Reduced carbon emissions by 144.9 tons through recycling 96.6 tons of waste methanol at the Guangzhou base.

Social Achievements

  • Enhanced employee engagement and happiness through diversification initiatives, including lectures, online courses, and management training.
  • Achieved zero reports of adverse reactions stemming from medication defects.
  • Reduced employee turnover by 1.95% compared to the previous year (from 15.26% to 13.31%).

Governance Achievements

  • Established a top-down ESG governance structure with a Board of Directors and an ESG Working Group.
  • Implemented the Quality Risk Management Procedures and established a comprehensive quality management system.
  • Formulated a comprehensive compliance management system incorporating international and domestic standards (ISO 37301).

Climate Goals & Targets

Medium-term Goals:
  • Reduce energy use intensity by 10% by 2028 (from 2023 baseline).
  • Reduce industrial wastewater discharge intensity by 10% by 2028 (from 2023 baseline).
  • Reduce greenhouse gas emission intensity by 10% by 2028 (from 2023 baseline).

Environmental Challenges

  • Operational risks
  • Adverse drug reaction risk
  • Financial risk
  • Credit risk
  • EHS risk
  • Compliance risk
  • Information security risk
  • Climate-related risks (acute physical, chronic physical, policy and regulations, reputational)
  • Non-climate related risks (not explicitly stated, but implied through general risk management discussion)
Mitigation Strategies
  • Systematic operational analysis and monthly risk assessments.
  • Effective adverse drug reaction event reporting mechanism.
  • Annual budget management, digital tools for efficiency, and capital reserves.
  • Strict distributor access system and accounts receivable management.
  • Comprehensive EHS training system and regular safety inspections.
  • Comprehensive compliance management system with internal audits and risk assessments.
  • Comprehensive information security management system with regular updates and employee training.
  • Integration of climate change risk management into daily work processes (ongoing).
  • Various risk management systems and procedures (detailed in the report).

Supply Chain Management

Supplier Audits: 0 in 2023 for environmental and social impacts; 2 on-site audits of entrusted manufacturers for quality management.

Responsible Procurement
  • Multi-dimensional background checks on suppliers.
  • Quality assessment questionnaires and on-site audits.
  • Regular quality re-audits.
  • Bi-weekly online meetings and annual on-site communication with key suppliers.
  • Periodic quality history evaluations.

Climate-Related Risks & Opportunities

Physical Risks
  • Acute physical risks (extreme weather events)
  • Chronic physical risks (long-term weather pattern changes)
Transition Risks
  • Policy and regulatory risks (changes in climate policies and regulations)
  • Reputational risks (failure to take proactive climate action)
Opportunities
  • Resource efficiency (improving resource use efficiency)
  • Adaptability (developing adaptability to climate change)

Reporting Standards

Frameworks Used: HKEX Environmental, Social and Governance Reporting Guide, Guidelines No. 2 for Application of Self-Regulation Rules for Companies Listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange

Certifications: ISO 14001 (Guangzhou InnoCare), ISO 45001 (Guangzhou InnoCare)

Awards & Recognition

  • China’s Top 20 Listed Pharmaceuticals in ESG Competitiveness 2023
  • Most Socially Responsible Pharmaceuticals of the 2023 Sina Finance “Golden Kirin”
  • List of Innovative Listed Pharmaceuticals of the 2023 Future Healthcare VB100 Awards
  • Top 10 Influential New Technologies and Products (ICP-332)
  • 3rd Excellent Healthcare Employer of the Year (2023)
  • Investor Relations Pioneer Award of iFinD Enterprise Account in 2022
  • China’s New Economy Enterprise Top 500 for 2022
  • Top 10 Innovative Pharmaceutical Enterprises of the Golden Walking Stick 2023